Encompass Health CorporationEHCNYSE
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank74
3Y CAGR-42.4%
5Y CAGR-14.6%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-42.4%/yr
Quarterly compound
5Y CAGR
-14.6%/yr
Recent deceleration
Percentile
P74
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 27.77% |
| Q3 2025 | 0.22% |
| Q2 2025 | -6.38% |
| Q1 2025 | 3.52% |
| Q4 2024 | 4.11% |
| Q3 2024 | 23.18% |
| Q2 2024 | -8.96% |
| Q1 2024 | 18.81% |
| Q4 2023 | -6.60% |
| Q3 2023 | 4.11% |
| Q2 2023 | -9.30% |
| Q1 2023 | 32.35% |
| Q4 2022 | 145.65% |
| Q3 2022 | -71.34% |
| Q2 2022 | 11.74% |
| Q1 2022 | 76.82% |
| Q4 2021 | -30.29% |
| Q3 2021 | -30.60% |
| Q2 2021 | 61.45% |
| Q1 2021 | -43.33% |
| Q4 2020 | 61.30% |
| Q3 2020 | -22.00% |
| Q2 2020 | 658.70% |
| Q1 2020 | -86.41% |
| Q4 2019 | 88.46% |
| Q3 2019 | -21.32% |
| Q2 2019 | -9.07% |
| Q1 2019 | -10.37% |
| Q4 2018 | -10.13% |
| Q3 2018 | 17.32% |
| Q2 2018 | -21.78% |
| Q1 2018 | 42.87% |
| Q4 2017 | -12.89% |
| Q3 2017 | 14.95% |
| Q2 2017 | -16.37% |
| Q1 2017 | 55.86% |
| Q4 2016 | -34.68% |
| Q3 2016 | 16.69% |
| Q2 2016 | -4.70% |
| Q1 2016 | 36.96% |